Oral trelagliptin administration (100 mg) once a week after breakfast

2 trials

Sponsors

Ise Red Cross Hospital Department of Metabolic Diseases, Ise Red Cross Hospital Department of Metabolic Diseases

Conditions

Patients with type 2 diabetes

Unknown Phase

The effect of trelagliptin on vascular endothelial functions in patients with type II diabetes mellitus.

Active, not recruitingJPRN-UMIN000018311

Ise Red Cross Hospital Department of Metabolic DiseasesPatients with type 2 diabetes

Start: 2015-07-17Target: 30Updated: 2026-06-29

Efficacy of trelagliptin for glucose fluctuation, oxidative stress and inflammation in patients with type 2 diabetes mellitus.

Active, not recruitingJPRN-UMIN000018334

Ise Red Cross Hospital Department of Metabolic DiseasesPatients with type 2 diabetes

Start: 2015-07-21Target: 20Updated: 2026-06-29

Related Papers

Effect of trelagliptin on vascular endothelial functions and serum adiponectin level in patients with type 2 diabetes: a preliminary single-arm prospective pilot study.

2016-11-0420 citations